CSIMarket
 


Lyra Therapeutics Inc   (LYRA)
Other Ticker:  
 

Cumulative Lyra Therapeutics Inc 's Quick Ratio for Trailing Twelve Months Period

LYRA's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

LYRA Quick Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth 41.38 % -46.4 % -35.56 % -20.69 % -23.45 %
Y / Y Cash & cash equivalent Growth -6.4 % -3.74 % 145.02 % 113.99 % 88.47 %
Quick Ratio for Trailing Twelve Months Period 7.46 8.48 7.78 5.97 4.81
Total Ranking # 361 # 362 # 377 # 601 # 763
Seq. Current Liabilities Growth 238.35 % -59.83 % -2.18 % 6.36 % 28.26 %
Seq. Cash & cash equivalent Growth -11.71 % 40.44 % -15.51 % -10.65 % -9.21 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to doubling in Current Liabilities in the III. Quarter to $19 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 7.46 below Lyra Therapeutics Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Equipment & Supplies industry 33 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Lyra Therapeutics Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about LYRA
Quick Ratio LYRA in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 34
Sector # 314
S&P 500 # 438


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
17.45 7.81 3.28
(Mar 31 2021)   (Mar 31 2022)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Medical Equipment & Supplies Industry Quick Ratio for Trailing Twelve Months Period
Talkspace Inc   18.83 
Alpha Tau Medical Ltd   18.34 
Innovative Eyewear Inc   16.58 
Vivos Inc  15.08 
Co diagnostics Inc   14.94 
Neurometrix Inc   14.47 
Modular Medical Inc   13.24 
Utah Medical Products Inc  13.19 
Vicarious Surgical Inc   12.69 
Cvrx inc  12.26 
Novocure Limited  11.72 
Collplant Biotechnologies Ltd   11.51 
Hyperfine Inc   11.45 
Transmedics Group Inc   11.28 
Heartbeam Inc   11.16 
Sight Sciences Inc   10.75 
Inmode Ltd   10.61 
Pulse Biosciences Inc   9.97 
Akili Inc   9.59 
Femasys Inc   9.16 
Rewalk Robotics Ltd   9.14 
Invivo Therapeutics Holdings Corp   8.05 
Lyra Therapeutics Inc   8.04 
Alpha Pro Tech Ltd   7.94 
Helius Medical Technologies inc   7.55 
Bone Biologics Corporation  7.46 
Aethlon Medical Inc   7.46 
Inspire Medical Systems inc   7.32 
Neuropace Inc   7.28 
Silk Road Medical Inc   7.25 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com